0

    540788

    ASPIRA

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Aspira Pathlab & Diagnostics L Share Price Today

    Investment Returns

    Over 1 Month -2.01% Over 3 Months 133.84% Over 6 Months 106.94% Over 1 Year 125.17%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Aspira Pathlab & Diagnostics L fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 132.50
    • P/E Ratio (TTM) 2,612.00
    • Beta 0.06
    • Book Value / share 11.88
    • Return on equity 16.88%
    • EPS (TTM) 0.05
    • Dividend yield [-]%
    • Net profit/quarter (Cr) -0.69
    info icon alternate text

    Aspira Pathlab & Diagnostics L Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 6.52
    Operating Expense 7.35
    Net Profit -0.69
    Net Profit Margin (%) -10.58
    Earnings Per Share (EPS) -0.67
    EBITDA -0.18
    Effective Tax Rate (%) 0.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 5.12
    Operating Expense 6.81
    Net Profit -1.56
    Net Profit Margin (%) -30.46
    Earnings Per Share (EPS) -1.52
    EBITDA -1.08
    Effective Tax Rate (%) 0.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 8.09
    Operating Expense 6.39
    Net Profit 1.84
    Net Profit Margin (%) 22.74
    Earnings Per Share (EPS) 1.78
    EBITDA 2.34
    Effective Tax Rate (%) 0.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 5.25
    Operating Expense 4.88
    Net Profit 0.47
    Net Profit Margin (%) 8.95
    Earnings Per Share (EPS) 0.46
    EBITDA 0.92
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 5.78
    Operating Expense 5.18
    Net Profit 0.72
    Net Profit Margin (%) 12.45
    Earnings Per Share (EPS) 0.70
    EBITDA 1.18
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 24.98
    Operating Expense 25.45
    Net Profit 0.05
    Net Profit Margin (%) 0.20
    Earnings Per Share (EPS) 0.05
    EBITDA 1.98
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 22.00
    Operating Expense 20.32
    Net Profit 2.07
    Net Profit Margin (%) 9.40
    Earnings Per Share (EPS) 2.01
    EBITDA 3.91
    Effective Tax Rate (%) 0.00
    Particulars MAR 2024 (Values in Cr)
    Revenue 13.20
    Operating Expense 16.30
    Net Profit -2.67
    Net Profit Margin (%) -20.22
    Earnings Per Share (EPS) -2.60
    EBITDA -0.75
    Effective Tax Rate (%) 0.00
    Particulars MAR 2023 (Values in Cr)
    Revenue 14.46
    Operating Expense 14.87
    Net Profit -0.09
    Net Profit Margin (%) -0.62
    Earnings Per Share (EPS) -0.09
    EBITDA 1.92
    Effective Tax Rate (%) 0.00
    Particulars MAR 2022 (Values in Cr)
    Revenue 19.54
    Operating Expense 15.18
    Net Profit 4.46
    Net Profit Margin (%) 22.82
    Earnings Per Share (EPS) 4.33
    EBITDA 6.47
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 7.03
    ROE % 16.47
    ROCE % 11.47
    Total Debt to Total Equity 0.15
    EBITDA Margin 17.59
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 5.07
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.15
    EBITDA Margin -5.76
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 7.08
    ROE % 16.88
    ROCE % 11.71
    Total Debt to Total Equity 0.15
    EBITDA Margin 17.82
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 5.07
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.16
    EBITDA Margin -5.76
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 7.60
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.20
    EBITDA Margin 13.28
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 7.64
    ROE % 23.08
    ROCE % 17.56
    Total Debt to Total Equity 0.19
    EBITDA Margin 33.11
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 3.29
    ROE % 15.17
    ROCE % 11.51
    Total Debt to Total Equity 0.70
    EBITDA Margin 24.46
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 2.14
    Total Assets 17.46
    Total Liabilities 17.46
    Total Equity 12.16
    Share Outstanding 1
    Price to Book Ratio 12.04
    Return on Assets (%) 11.58
    Return on Capital (%) 15.12
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1.38
    Total Assets 14.70
    Total Liabilities 14.70
    Total Equity 10.14
    Share Outstanding 1
    Price to Book Ratio 6.11
    Return on Assets (%) -18.16
    Return on Capital (%) -23.82
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 2.14
    Total Assets 17.51
    Total Liabilities 17.51
    Total Equity 12.21
    Share Outstanding 1
    Price to Book Ratio 12.04
    Return on Assets (%) 11.83
    Return on Capital (%) 15.44
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1.38
    Total Assets 14.70
    Total Liabilities 14.70
    Total Equity 10.14
    Share Outstanding 1
    Price to Book Ratio 6.11
    Return on Assets (%) -18.16
    Return on Capital (%) -23.82
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 2.34
    Total Assets 17.34
    Total Liabilities 17.34
    Total Equity 12.75
    Share Outstanding 1
    Price to Book Ratio 3.66
    Return on Assets (%) -0.51
    Return on Capital (%) -0.65
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1.64
    Total Assets 18.13
    Total Liabilities 18.13
    Total Equity 12.78
    Share Outstanding 1
    Price to Book Ratio 8.48
    Return on Assets (%) 24.58
    Return on Capital (%) 32.67
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 1.18
    Total Assets 11.77
    Total Liabilities 11.77
    Total Equity 8.31
    Share Outstanding 1
    Price to Book Ratio 8.66
    Return on Assets (%) 11.72
    Return on Capital (%) 14.44
    Particulars MAR 2025 (Values in Cr)
    Net Income 2.02
    Cash from Operations 1.82
    Cash from Investing 0.11
    Cash from Financing -0.99
    Net change in Cash 0.94
    Free Cash Flow 2.17
    Particulars MAR 2024 (Values in Cr)
    Net Income -2.67
    Cash from Operations 1.05
    Cash from Investing 0.13
    Cash from Financing -0.95
    Net change in Cash 0.23
    Free Cash Flow 1.31
    Particulars MAR 2025 (Values in Cr)
    Net Income 2.07
    Cash from Operations 1.87
    Cash from Investing 0.06
    Cash from Financing -0.99
    Net change in Cash 0.94
    Free Cash Flow 2.22
    Particulars MAR 2024 (Values in Cr)
    Net Income -2.67
    Cash from Operations 1.05
    Cash from Investing 0.13
    Cash from Financing -0.95
    Net change in Cash 0.23
    Free Cash Flow 1.31
    Particulars MAR 2023 (Values in Cr)
    Net Income -0.08
    Cash from Operations -0.01
    Cash from Investing 0.15
    Cash from Financing -0.93
    Net change in Cash -0.78
    Free Cash Flow 0.11
    Particulars MAR 2022 (Values in Cr)
    Net Income 4.45
    Cash from Operations 2.03
    Cash from Investing -0.51
    Cash from Financing -1.35
    Net change in Cash 0.16
    Free Cash Flow 2.62
    Particulars MAR 2021 (Values in Cr)
    Net Income 1.38
    Cash from Operations 5.67
    Cash from Investing -0.09
    Cash from Financing -2.17
    Net change in Cash 3.40
    Free Cash Flow 5.79
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8659.30 63.65 13.14 124507.45 6680.00 8730.60
    FORTIS MALAR HOSPITALS LIMITED 52.31 23.67 2.85 98.04 40.75 76.00
    SHREE PACETRONIX LTD. 125.25 14.95 2.63 46.96 71.00 283.15
    TRANSGENE BIOTEK LTD. 3.13 0.00 2.83 23.72 1.83 5.26
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8659.30 82.94 12.49 124507.45 6680.00 8730.60
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 39.40 0.00 -9.58 29.43 30.30 57.48
    KOVAI MEDICAL CENTER & HO 5952.40 26.64 4.93 6511.93 5010.00 6725.00

    Aspira Pathlab & Diagnostics L shareholding pattern

    Holding
    81.6%
    18.39%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Aspira Pathlab & Diagnostics L Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    128.70 -1.45 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 128.30
    • 26 Days 117.50
    • 10 Days 125.80
    • 50 Days 104.10
    • 12 Days 125.00
    • 100 Days 88.70
    • 20 Days 121.10
    • 200 Days 76.90
    130.57 PIVOT
    First Support 130.53 First Resistance 130.63 Second Support 130.47 Second Resistance 130.67 Third Support 130.43 Third Resistance 130.73
    RSI 73.11 ADX 32.87 MACD 7.51 Williams % R -4.22 Commodity Channel Index (CCI) 129.72
    Date 2026-06-29 Week 1869.00 Same Day 667.00 Month 2857.00
    1 Year 0.06 3 Year 0.09
    Over 1 Month
    -2.01% down
    Over 1 Year
    125.17% down
    Over 3 Months
    133.84% down
    Over 3 Years
    66.21% down
    Over 6 Months
    106.94% down
    Over 5 Years
    33.02% down

    Aspira Pathlab & Diagnostics L Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Aspira Pathlab & Diagnostics Ltd?

    Answer Field

    Aspira Pathlab & Diagnostics Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 128.70 as on Jun 30 2026 03:15 PM.

    What is the Market Cap of Aspira Pathlab & Diagnostics Ltd Share?

    Answer Field

    The market cap of Aspira Pathlab & Diagnostics Ltd for NSE ₹ 0.00 & for BSE ₹ 132.50 as on Jun 30 2026 03:15 PM.

    What is the 52 Week High and Low of Aspira Pathlab & Diagnostics Ltd?

    Answer Field

    The 52 Week High and Low of Aspira Pathlab & Diagnostics Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 135.88 and ₹ 49.00.

    What is 1 year return for Aspira Pathlab & Diagnostics Ltd?

    Answer Field

    The 1 year returns on the stock has been 125.17%.

    What is the P/E Ratio of Aspira Pathlab & Diagnostics Ltd Share?

    Answer Field

    As on Jun 30 2026 03:15 PM the price-to-earnings (PE) ratio for Aspira Pathlab & Diagnostics Ltd share is 2612.00.

    What is the PB ratio of Aspira Pathlab & Diagnostics Ltd Share?

    Answer Field

    As on Jun 30 2026 03:15 PM, the price-to-book (PB) ratio for Aspira Pathlab & Diagnostics Ltd share is 11.88.

    How to Buy Aspira Pathlab & Diagnostics Ltd Share?

    Answer Field

    You can trade in Aspira Pathlab & Diagnostics Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Aspira Pathlab & Diagnostics Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Aspira Pathlab & Diagnostics Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Aspira Pathlab & Diagnostics Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |